FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379967701> ?p ?o ?g. }

• W4379967701 abstract "Type 2 diabetes mellitus (T2DM) individuals are at a higher risk of developing diabetes complications, with approximately 80% complication-related mortality. The increased morbidity and mortality among T2DM patients are partly due to dysregulated hemostasis. This study determined the quality of glycemic control in T2DM and its association with markers of coagulation and inhibitors of fibrinolysis.This case-control study recruited 90 participants involving: 30 T2DM patients with good glycemic control, 30 with poor glycemic control, and 30 nondiabetic subjects as controls at a Municipal Hospital in Ghana. Fasting blood glucose, glycated hemoglobin, activated partial thromboplastin time (APTT), prothrombin time (PT), calculated international normalized ratio (INR), and full blood count (FBC) were determined for each respondent. Plasma levels of plasminogen activator inhibitor-1 (PAI-1) and thrombin activatable fibrinolysis inhibitor (TAFI) were determined using the solid-phase sandwich enzyme-linked immunosorbent assay method. Data were analyzed using R language software.Plasma PAI-1 antigen levels were significantly higher in the participants with poor glycemic control as compared to participants with good glycemic control (p < 0.0001). There was no significant difference in plasma TAFI levels between the participants with poor glycemic control as compared to participants with good glycemic control (p = 0.900). T2DM patients had significantly shorter APTT, PT, and INR than controls (p < 0.05). At a cut-off of ≥161.70 pg/μL, PAI was independently associated with increasing odds (adjusted odds ratio = 13.71, 95% confidence interval: 3.67-51.26, p < 0.0001) of poor glycemic control and showed the best diagnostic accuracy for poor glycemic control (area under the curve = 0.85, p < 0.0001).PAI-1 levels were significantly increased in T2DM with poor glycemic control and emerged as the best predictor for poor glycemic control. Good glycemic management to control the plasma levels of PAI-1 is required to prevent hypercoagulability and thrombotic disorders." @default.
• W4379967701 created "2023-06-10" @default.
• W4379967701 creator A5016176266 @default.
• W4379967701 creator A5016297892 @default.
• W4379967701 creator A5018798153 @default.
• W4379967701 creator A5019484177 @default.
• W4379967701 creator A5020921099 @default.
• W4379967701 creator A5030202332 @default.
• W4379967701 creator A5034962710 @default.
• W4379967701 creator A5044194891 @default.
• W4379967701 creator A5046438320 @default.
• W4379967701 creator A5048438440 @default.
• W4379967701 creator A5049274923 @default.
• W4379967701 creator A5050477449 @default.
• W4379967701 creator A5058530007 @default.
• W4379967701 creator A5060379282 @default.
• W4379967701 creator A5064292242 @default.
• W4379967701 creator A5072907709 @default.
• W4379967701 creator A5092121783 @default.
• W4379967701 creator A5092121784 @default.
• W4379967701 date "2023-06-01" @default.
• W4379967701 modified "2023-10-04" @default.
• W4379967701 title "Quality of glycemic control in type 2 diabetes mellitus (T2DM) and its association with markers of coagulation and inhibitors of fibrinolysis: A case–control study in the Upper West Region, Ghana" @default.
• W4379967701 cites W11598776 @default.
• W4379967701 cites W1589733194 @default.
• W4379967701 cites W1941255455 @default.
• W4379967701 cites W1974895405 @default.
• W4379967701 cites W1996014308 @default.
• W4379967701 cites W2000013300 @default.
• W4379967701 cites W2013916385 @default.
• W4379967701 cites W2046768393 @default.
• W4379967701 cites W2067475695 @default.
• W4379967701 cites W2074134943 @default.
• W4379967701 cites W2089548328 @default.
• W4379967701 cites W2113519759 @default.
• W4379967701 cites W2127764309 @default.
• W4379967701 cites W2148081733 @default.
• W4379967701 cites W2152377123 @default.
• W4379967701 cites W2317366912 @default.
• W4379967701 cites W2586701863 @default.
• W4379967701 cites W2592424182 @default.
• W4379967701 cites W2761622915 @default.
• W4379967701 cites W2885296520 @default.
• W4379967701 cites W2890740973 @default.
• W4379967701 cites W2979984985 @default.
• W4379967701 cites W2995691142 @default.
• W4379967701 cites W3020365567 @default.
• W4379967701 cites W3024292764 @default.
• W4379967701 cites W3133888144 @default.
• W4379967701 cites W3139057924 @default.
• W4379967701 cites W3156586545 @default.
• W4379967701 cites W4251240079 @default.
• W4379967701 cites W7687383 @default.
• W4379967701 doi "https://doi.org/10.1002/hsr2.1297" @default.
• W4379967701 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37292102" @default.
• W4379967701 hasPublicationYear "2023" @default.
• W4379967701 type Work @default.
• W4379967701 citedByCount "0" @default.
• W4379967701 crossrefType "journal-article" @default.
• W4379967701 hasAuthorship W4379967701A5016176266 @default.
• W4379967701 hasAuthorship W4379967701A5016297892 @default.
• W4379967701 hasAuthorship W4379967701A5018798153 @default.
• W4379967701 hasAuthorship W4379967701A5019484177 @default.
• W4379967701 hasAuthorship W4379967701A5020921099 @default.
• W4379967701 hasAuthorship W4379967701A5030202332 @default.
• W4379967701 hasAuthorship W4379967701A5034962710 @default.
• W4379967701 hasAuthorship W4379967701A5044194891 @default.
• W4379967701 hasAuthorship W4379967701A5046438320 @default.
• W4379967701 hasAuthorship W4379967701A5048438440 @default.
• W4379967701 hasAuthorship W4379967701A5049274923 @default.
• W4379967701 hasAuthorship W4379967701A5050477449 @default.
• W4379967701 hasAuthorship W4379967701A5058530007 @default.
• W4379967701 hasAuthorship W4379967701A5060379282 @default.
• W4379967701 hasAuthorship W4379967701A5064292242 @default.
• W4379967701 hasAuthorship W4379967701A5072907709 @default.
• W4379967701 hasAuthorship W4379967701A5092121783 @default.
• W4379967701 hasAuthorship W4379967701A5092121784 @default.
• W4379967701 hasBestOaLocation W43799677011 @default.
• W4379967701 hasConcept C126322002 @default.
• W4379967701 hasConcept C134018914 @default.
• W4379967701 hasConcept C146304588 @default.
• W4379967701 hasConcept C156957248 @default.
• W4379967701 hasConcept C2776825266 @default.
• W4379967701 hasConcept C2777180221 @default.
• W4379967701 hasConcept C2777538456 @default.
• W4379967701 hasConcept C2778261982 @default.
• W4379967701 hasConcept C2778382381 @default.
• W4379967701 hasConcept C2778589496 @default.
• W4379967701 hasConcept C2779306644 @default.
• W4379967701 hasConcept C2780434524 @default.
• W4379967701 hasConcept C2780473172 @default.
• W4379967701 hasConcept C2910068830 @default.
• W4379967701 hasConcept C44249647 @default.
• W4379967701 hasConcept C555293320 @default.
• W4379967701 hasConcept C71924100 @default.
• W4379967701 hasConcept C90924648 @default.
• W4379967701 hasConceptScore W4379967701C126322002 @default.
• W4379967701 hasConceptScore W4379967701C134018914 @default.
• W4379967701 hasConceptScore W4379967701C146304588 @default.
• W4379967701 hasConceptScore W4379967701C156957248 @default.

• next